BioInsights - Home page

IMMUNO-ONCOLOGY INSIGHTS

April 2023 Issue

Vol 4 Issue 3

Modality/platform development trends

Featuring this month's spotlight content:

Modality/platform development trends
View
Immuno-Oncology Vol 4 Issue 3
View

Latest Articles

Supporting I–O combination therapy development with correlative assays & biomarker discovery

Supporting I–O combination therapy development with correlative assays & biomarker discovery

Ana Rosa Saez Ibanez, Samik Upadhaya
14 May 2023
Interview
From highs & lows to steady progress: assessing the shifting I–O clinical landscape

From highs & lows to steady progress: assessing the shifting I–O clinical landscape

Andrew Baum
13 May 2023
Interview
Fueling cancer research efforts with patient biospecimen collection & big data

Fueling cancer research efforts with patient biospecimen collection & big data

Ronan Kelly
13 May 2023
Interview
Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Sylvia F Boj, Andrea Bisso
8 May 2023
Innovator Insight
Trialing reovirus in combination for I–O applications

Trialing reovirus in combination for I–O applications

Houra Loghmani
3 May 2023
Interview
Spotlight on modality & platform development trends

Spotlight on modality & platform development trends

David Dilillo
1 May 2023
Foreword
Assessing efficacy & MoA of mono & combo immunotherapies in preclinical humanized models

Assessing efficacy & MoA of mono & combo immunotherapies in preclinical humanized models

K Thiam, A Surya, E van der Horst
25 April 2023
Innovator Insight
Alloplex Biotherapeutic’s SUPLEXA cells represent a new type of autologous adoptive cellular therapy for cancer

Alloplex Biotherapeutic’s SUPLEXA cells represent a new type of autologous adoptive cellular therapy for cancer

Frank Borriello, James A Lederer
24 April 2023
Commentary
Accelerating cancer therapies development: the importance of platform, process, and partnership

Accelerating cancer therapies development: the importance of platform, process, and partnership

W Swaney, J Shyu, N Tyagi
22 April 2023
Expert Roundtable

Channel content